Asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, interacts with gastric oxidative metabolism and enhances stress-induced gastric lesions

Journal of Physiology and Pharmacology

Volumn 63, Issue 5, 2012, Pages 515-524

  Kwiecien, S ^a   Ptak Belowska, A ^a   Krzysiek Maczka, G ^a   Targosz, A ^a   Jasnos, K ^a   Magierowski, M ^a   Szczyrk, U ^a   Brzozowski, B ^a   Konturek, S J ^a   Konturek, P C ^b   Brzozowski, T ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Asymmetric dimethylarginine; Glutathione peroxidase; Interleukin 1 ; Malonylaldehyde; Oxidative stress; Superoxide dismutase; Tumor necrosis factor ; Water immersion restraint stress

Indexed keywords

GLUTATHIONE PEROXIDASE; GLYCERYL TRINITRATE; INTERLEUKIN 1BETA; N(G),N(G) DIMETHYLARGININE; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA;

ACUTE DISEASE; AEROBIC METABOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DOPPLER FLOWMETRY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMOBILIZATION STRESS; LIPID PEROXIDATION; MALE; NONHUMAN; OXIDATIVE STRESS; PROTEIN BLOOD LEVEL; PROTEIN DEPLETION; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; STOMACH BLOOD FLOW; STOMACH LESION; STOMACH MUCOSA; ULCEROGENESIS; WATER IMMERSION;

ALDEHYDES; ANIMALS; ARGININE; ENZYME INHIBITORS; GASTRIC MUCOSA; GLUTATHIONE PEROXIDASE; INTERLEUKIN-1BETA; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; NITRIC OXIDE SYNTHASE; RATS; RATS, WISTAR; REGIONAL BLOOD FLOW; RESTRAINT, PHYSICAL; STOMACH ULCER; STRESS, PSYCHOLOGICAL; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84870614358     PISSN: 08675910     EISSN: 18991505     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Kwiecien S, Brzozowski T, Konturek SJ. Effects of reactive oxygen species action on gastric mucosa in various models of mucosal injury. J Physiol Pharmacol 2002; 53: 39-50.
2. Kwiecien S, Brzozowski T, Konturek PC, et al. Gastroprotection by pentoxyfilline against stress-induced gastric damage. Role of lipid peroxidation, antioxidizing enzymes and proinflammatory cytokines. J Physiol Pharmacol 2004; 55: 337-355.
3. Kwiecien S, Konturek PC, Sliwowski Z, et al. Interaction between selective cyclooxygenase inhibitors and capsaicin-sensitive afferent sensory nerves in pathogenesis of stress - induced gastric lesions. Role of oxidative stress. J Physiol Pharmacol 2012; 63: 143-151.
4. Kwiecien S, Brzozowski T, Konturek PC, et al. The role of reactive oxygen species and capsaicin-sensitive sensory nerves in the pathomechanism of gastric ulcers induced by stress. J Physiol Pharmacol 2003; 54: 423-437.
5. Kwiecien S, Pawlik MW, Brzozowski T, et al. Nitric oxide (NO)-releasing aspirin and other (NO) donors in protection of gastric mucosa against stress. J Physiol Pharmacol 2008; 59(Suppl. 2): 103-115.
6. Kwiecien S, Pawlik MW, Brzozowska I, et al. Effect of vasodilators on lipid peroxidation and antioxidative mechanisms in gastric mucosa [in Polish]. Clin Exp Med Lett 2005; 46: 33-38.
7. Konturek SJ, Konturek PC. Role of nitric oxide in digestive system. Digestion 1995; 56: 1-13.
8. Brzozowski T, Konturek PC, Pajdo R, et al. Physiological mediators in nonsteroidal anti-inflammatory drugs (NSAIDs)-induced impairment of gastric mucosal defense and adaptation. Focus on nitric oxide and lipoxins. J Physiol Pharmacol 2008; 59(Suppl. 2): 89-102.
9. Brzozowska I, Targosz A, Sliwowski Z, et al. Healing of chronic gastric ulcers in diabetic rats treated with native aspirin, nitric oxide (NO)-derivative of aspirin and cyclooxygenase (COX)-2 inhibitor. J Physiol Pharmacol 2004; 55: 773-790.
10. Fiedler L. The DDAH/ADMA pathway is a critical regulator of NO signalling in vascular homeostasis. Cell Adh Migr 2008; 2: 149-150.
11. Böger RH, Bode-Böger SM, Szuba A, et al. Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia. Circulation 1998; 98: 1842-1847.
12. Böger RH. The emerging role of ADMA as a novel cardiovascular risk factor. Cardiovasc Res 2003; 59: 824-833.
13. Wang L, Zhou Y, Peng J, Zhang Z, Jiang DJ, Li YJ. Role of endogenous nitric oxide synthase inhibitor in gastric mucosal injury. Can J Physiol Pharmacol 2008; 86: 97-104.
14. Gorenflo M, Zheng C, Werle E, Fiehn W, Ulmer HE. Plasma levels of asymmetrical dimethyl-L-arginine in patients with congenital heart disease and pulmonary hypertension. J Cardiovasc Pharmacol 2001; 37: 489-492.
15. Wells SM, Holian A. Asymmetric dimethylarginine induces oxidative and nitrosative stress in murine lung epithelial cells. Am J Respir Cell Mol Biol 2007; 36: 520-528.
16. Yuan Q, Jiang DJ, Chen QQ, et al. Role of asymmetric dimethylarginine in homocysteine-induced apoptosis of vascular smooth muscle cells. Biochem Biophys Res Commun 2007; 356: 880-885.
17. Briet M, Burns KD. Chronic kidney disease and vascular remodeling: molecular mechanisms and clinical implications. Clin Sci 2012; 123: 399-416.
18. Das UN, Repossi G, Eynard AR. L-arginine, NO and asymmetrical dimethylarginine in hypertension and type 2 diabetes. Front Biosci 2011; 16: 13-20.
19. Arrigoni F, Ahmetaj B, Leiper J. The biology and therapeutic potential of the DDAH/ADMA pathway. Curr Pharm Des 2010; 16: 4089-4102.
20. Razny U, Kiec-Wilk B, Polus A, et al. The adipose tissue gene expression in mice with different nitric oxide availability. J Physiol Pharmacol 2010; 61: 607-618.
21. Li L, Luo XJ, Liu YZ, et al. The role of the DDAH-ADMA pathway in the protective effect of resveratrol analog BTM-0512 on gastric mucosal injury. Can J Physiol Pharmacol 2010; 88: 562-567.
22. Zhang Z, Zou YY, Li FJ, Hu CP. Asymmetric dimethylarginine: a novel biomarker of gastric mucosal injury? World J Gastroenterol 2011; 17: 2178-2180.
23. Brzozowski T, Konturek PC, Konturek SJ, et al. Implications of reactive oxygen species and cytokines in gastroprotection against stress-induced gastric damage by nitric oxide releasing aspirin. Int J Colorectal Dis 2003; 18: 320-329.
24. Takagi KY, Kayuya Y, Watanabe K. Studies on drugs for peptic ulcer. A reliable method for producing stress ulcers in rats. Chem Pharm Bull 1964; 12: 465-472.
25. Konturek PC, Brzozowski T, Burnat G, et al. Gastric ulcer healing and stress-lesion preventive properties of pioglitazone are attenuated in diabetic rats. J Physiol Pharmacol 2010; 61: 429-436.
26. Chomczynski J, Sacchi N. A single step method of RNA isolation by acid guanidinum thiocyanate. Anal Biol Chem 1987; 162: 156-159.
27. Konturek PC, Duda A, Brzozowski T, et al. Activation of genes for superoxide dismutase, interleukin-1β, tumor necrosis factor-α and intercellular adhesion molecule-1 during healing of ischemia-reperfusion gastric injury. Scand J Gastroenterol 2000; 35: 452-463.
28. Miyamoto S, Dupas C, Murota K, Terao J. Phospholipid hydroperoxides are detoxified by phospholipase A2 and GSH peroxidase in rat gastric mucosa. Lipids 2003; 38; 641-649.
29. Altinkaynak K, Suleyman H, Akcay F. Effect of nimesulfide, rofecoxib and celecoxib on gastric tissue glutathione level in rats with indomethacin-induced gastric ulcerations. Pol J Pharmacol 2003; 55: 645-648.
30. Leiper J, Nandi M. The therapeutic potential of targeting endogenous inhibitors of nitric oxide synthesis. Nat Rev Drug Discov 2011; 10: 277-291.
31. von Bothmer C, Edebo A, Lönroth H, Olbe L, Pettersson A, Fändriks L. Helicobacter pylori infection inhibits antral mucosal nitric oxide production in humans. Scand J Gastroenterol 2002; 37: 404-408.
32. Henriksnas J, Atuma C, Phillipson M, Sandler S, Engstrand L, Holm L. Acute effects of Helicobacter pylori extracts on gastric mucosal blood flow in the mouse. World J Gastroenterol 2009; 15: 219-225.